Apple Watch Receives FDA Approval to Evaluate Sleep Apnea

Apple (NASDAQ:AAPL) Watching a movie all day won’t save you from a visit to the doctor, but it can help detect sleep apnea.

Apple today received approval from the U.S. Food and Drug Administration to use the Apple Watch to assess sleep apnea. risk.

The feature will be available on Series 9, Series 10, and Watch Ultra 2. The Series 10 is scheduled to launch on Friday, September 20.

“This device uses software algorithms to analyze sensor inputs and provide an assessment of the risk of sleep apnea,” the FDA said. “It is not intended to self-diagnose, replace traditional methods of diagnosis (e.g., polysomnography), assist physicians in diagnosing sleep disorders, or monitor apnea.”

This is the second time in two weeks that an Apple product has received FDA approval. Last week, the FDA granted Apple approval for software that allows AirPods Pro 2 to be used as an over-the-counter hearing aid.

FDA approvals show that Apple places great importance on finding health uses for its products.

“At Apple, we believe technology can help you live healthier lives, and we’re excited to deliver incredible new healthcare capabilities for serious medical conditions that affect billions of people around the world, while protecting the privacy of our users’ data,” said Sumbul Desai, MD, Apple’s senior vice president of Health.

Apple dropped by 3% during Monday morning in the markets.